Verapamil-induced secondary erythermalgia
- 1 September 1992
- journal article
- Published by Wiley in British Journal of Dermatology
- Vol. 127 (3) , 292-294
- https://doi.org/10.1111/j.1365-2133.1992.tb00132.x
Abstract
Summary A 59-year-old man developed red, swollen and warm feet accompanied by intermittent burning pain during treatment for cardiac failure and arrhythmias with several drugs including verapamil. The condition gradually worsened until there was persistent disabling burning pain and severe erythema and swelling of the feet. Aspirin and other analgesics were ineffective in relieving the discomfort. Histopathology of punch biopsies showed a mild perivascular mononuclear infiltrate and moderate perivascular oedema. Within 2 weeks of stopping verapamil the burning pain, erythema, and swelling of the feet had resolved. The clinical features and subsequent course are consistent with a diagnosis of erythermalgia secondary to verapamil.Keywords
This publication has 13 references indexed in Scilit:
- Three types of erythromelalgia.BMJ, 1990
- Erythromelalgia and thrombocythemia: A causal relationJournal of the American Academy of Dermatology, 1990
- Idiopathic erythermalgia: A congenital disorderJournal of the American Academy of Dermatology, 1989
- VerapamilDrugs, 1989
- Erythromelalgia induced by nicardipine (inverse Raynaud's phenomenon?).BMJ, 1989
- Cutaneous Reactions to NifedipineDermatology, 1987
- Erythromelalgia following pergolide administrationBritish Journal of Dermatology, 1984
- Nifedipine and ErythromelalgiaAnnals of Internal Medicine, 1983
- Erythromelalgia‐like eruption in parkinsonian patients treated with bromocriptineNeurology, 1981
- LONG-TERM TREATMENT OF PARKINSONISM WITH BROMOCRIPTINEThe Lancet, 1978